Product Information
TOPIRAMATE 25 MG SPRINKLE CAP is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2459 per EA under NDC 23155089506. Its NADAC has been published 108 times since Sep 11, 2024.
FDA first approved this application on Oct 14, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155089506
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA078418FDA Approved
10/14/2009
TE Code
AB
On Market Since
2/16/2024
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has been published 108 times since Sep 11, 2024, and over the history we have for it it has declined 58.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2459 per EA |
|---|---|
| All-time high | $0.6024 (Oct 16, 2024) |
| All-time low | $0.2459 (Sep 23, 2026) |
| 52-week high | $0.4019 |
| 52-week low | $0.2459 |
| Median price | $0.3911 |
| Average price | $0.3928 |
| Largest weekly change | -25.0% (Nov 20, 2024) |
| Weeks tracked | 108 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the topiramate spinkle market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
topiramate spinkle market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 25 MG SPRINKLE CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG SPRINKLE CAP, manufactured by Heritage Pharmaceuticals Inc., is $0.2459 per EA (NDC 23155089506), effective Sep 30, 2026.
How has the price of TOPIRAMATE 25 MG SPRINKLE CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has declined 58.0%. It has been tracked across 108 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG SPRINKLE CAP?
Since Sep 11, 2024, the NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has ranged from a low of $0.2459 (Sep 23, 2026) to a high of $0.6024 (Oct 16, 2024), with a median of $0.3911 per EA.
Are there cheaper alternatives to TOPIRAMATE 25 MG SPRINKLE CAP?
No other NADAC-published product currently shares the active ingredient and strength of TOPIRAMATE 25 MG SPRINKLE CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOPIRAMATE 25 MG SPRINKLE CAP?
TOPIRAMATE 25 MG SPRINKLE CAP (NDC 23155089506) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.